Weight loss in patients on osimertinib for metastatic EGFR-mutant non-small cell lung cancer

Chen, L. N., Ma, X., Herzberg, B., Henick, B. S., Biswas, A. K., Acharyya, S., & Shu, C. A. (2024). Weight loss in patients on osimertinib for metastatic EGFR-mutant non-small cell lung cancer. The Oncologist. https://doi.org/10.1093/oncolo/oyae315
Authors:
Lanyi Nora Chen
Hanxin Wu
Benjamin Herzberg
Brian S. Henick
A. Biswas
Swarnali Acharyya
Catherine A. Shu
Affiliated Authors:
Lanyi Nora Chen
Hanxin Wu
Benjamin Herzberg
Brian S. Henick
A. Biswas
Swarnali Acharyya
Catherine A. Shu
Columbia Affiliation:
Subjects:
Gastric Cancer Research and Treatment (OpenAlex Topic)
Sarcopenia: Definition, Diagnosis, and Implications (OpenAlex Topic)
Cancer of Unknown Primary Site (OpenAlex Topic)
Author Keywords:
egfr-mutant
cachexia
non-small cell lung cancer
osimertinib
elink
Publication Type:
Article
Unique ID:
10.1093/oncolo/oyae315
PMID:
39703162
DOI:
10.1093/oncolo/oyae315
Journal:
Oncologist
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record

Record Created: